Nicole L. Michmerhuizen

University of Rochester

Associate Professor(heuristic)

Acute Myeloid Leukemia Research · Hematology

h-index14

i10-index16

Publications92

Citations698

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 27

Condensates in fusion oncoprotein-driven leukemia: new biology and therapeutic opportunities
Trends in cancer · 2026-06-01
Figure 3 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Figure 2 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Figure 6 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Figure 7 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Figure 4 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Figure 5 from Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation
2025-12-09
Ectopic BCL11B disrupts the activity of early hematopoietic transcription factors to skew lineage commitment
Blood · 2025-11-03
Data from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S6 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S5 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S2 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Tables S1-S17 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S7 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06 · 1 citations
Supplementary Figure S3 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S1 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06 · 1 citations
Supplementary Methods and Results from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S8 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Supplementary Figure S4 from KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i>-Rearranged Acute Myeloid Leukemia
2025-10-06
Fusion oncoproteins and cooperating mutations define disease phenotypes in <i>NUP98</i> -rearranged leukemia
Blood · 2025-07-23 · 8 citations

Open author page on OpenAlex →